D. Scheller

2.9k total citations
111 papers, 2.3k citations indexed

About

D. Scheller is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, D. Scheller has authored 111 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 30 papers in Molecular Biology and 30 papers in Cellular and Molecular Neuroscience. Recurrent topics in D. Scheller's work include Neuroscience and Neuropharmacology Research (24 papers), Parkinson's Disease Mechanisms and Treatments (21 papers) and Neurological disorders and treatments (12 papers). D. Scheller is often cited by papers focused on Neuroscience and Neuropharmacology Research (24 papers), Parkinson's Disease Mechanisms and Treatments (21 papers) and Neurological disorders and treatments (12 papers). D. Scheller collaborates with scholars based in Germany, Belgium and United Kingdom. D. Scheller's co-authors include J. Kolb, F. Tegtmeier, H. Spies, Thomas Wolff, Hermann Lübbert, Reinhard Berkels, Christoph Ullmer, Xiuling Yu, О. Rademacher and Martyn Wood and has published in prestigious journals such as PLoS ONE, Macromolecules and Journal of Neurophysiology.

In The Last Decade

D. Scheller

107 papers receiving 2.2k citations

Peers

D. Scheller
James Z. Ginos United States
Stephen M. Moerlein United States
Peter Bjurling Sweden
G. Zürcher Switzerland
Angela Monopoli Italy
M. Da Prada Switzerland
Kay Castagnoli United States
Toshiaki Irie Japan
Peter K. H. Wong Canada
Per‐Göran Gillberg Sweden
James Z. Ginos United States
D. Scheller
Citations per year, relative to D. Scheller D. Scheller (= 1×) peers James Z. Ginos

Countries citing papers authored by D. Scheller

Since Specialization
Citations

This map shows the geographic impact of D. Scheller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Scheller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Scheller more than expected).

Fields of papers citing papers by D. Scheller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Scheller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Scheller. The network helps show where D. Scheller may publish in the future.

Co-authorship network of co-authors of D. Scheller

This figure shows the co-authorship network connecting the top 25 collaborators of D. Scheller. A scholar is included among the top collaborators of D. Scheller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Scheller. D. Scheller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santos, Márcia Cristina Teixeira dos, D. Scheller, Claudia Schulte, et al.. (2018). Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis. PLoS ONE. 13(11). e0206536–e0206536. 34 indexed citations
2.
Michel, Anne, Sarah Rose, Michael S. Jackson, et al.. (2017). Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets. PLoS ONE. 12(8). e0182887–e0182887. 13 indexed citations
3.
Stamford, Jon, D. Scheller, & Peter Jenner. (2016). Parkinson’s Inside Out. Journal of Parkinson s Disease. 6(1). 65–66. 1 indexed citations
4.
Höglinger, Günter U., Daniel Alvarez‐Fischer, Óscar Arias-Carrión, et al.. (2015). A new dopaminergic nigro-olfactory projection. Acta Neuropathologica. 130(3). 333–348. 94 indexed citations
5.
Michel, Anne, Patrick Downey, Jean‐Marie Nicolas, & D. Scheller. (2014). Unprecedented Therapeutic Potential with a Combination of A2A/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease. PLoS ONE. 9(12). e114086–e114086. 19 indexed citations
6.
Radad, Khaled, et al.. (2014). Original article Neuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture. Folia Neuropathologica. 2(2). 179–186. 8 indexed citations
7.
Jenner, Peter, Andrew C. McCreary, & D. Scheller. (2011). Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression. Journal of Neural Transmission. 118(12). 1691–1702. 37 indexed citations
8.
Scheller, D., Sarah Rose, Michael S. Jackson, et al.. (2009). Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction. Experimental Neurology. 219(2). 533–542. 38 indexed citations
9.
Scheller, D., et al.. (2008). The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson’s disease. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(1). 73–86. 124 indexed citations
10.
Scheller, D., N. Dürmüller, Paul Moser, & Roger D. Porsolt. (2008). Continuous stimulation of dopaminergic receptors by rotigotine does not interfere with the sleep–wake cycle in the rat. European Journal of Pharmacology. 584(1). 111–117. 12 indexed citations
11.
Schmidt, Werner, et al.. (2008). Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements. Journal of Neural Transmission. 115(10). 1385–1392. 31 indexed citations
12.
Rose, Sarah, et al.. (2007). Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates. Behavioural Pharmacology. 18(2). 155–160. 17 indexed citations
13.
14.
Scheller, D., Piu Chan, Qin Li, et al.. (2006). Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease. Experimental Neurology. 203(2). 415–422. 36 indexed citations
15.
Gorji, Ali, et al.. (2003). The Lateral Spread of Epileptiform Discharges in Rat Neocortical Slices: Effect of Focal Phencyclidine Application. Pharmacopsychiatry. 36(3). 113–120. 4 indexed citations
16.
Großmann, G., D. Scheller, Olga L. Malkina, et al.. (2000). Experimental and Theoretical 31P and 77Se Nuclear Magnetic Shielding Tensors for Bis(dineopentoxyphosphorothioyl) Diselenide. Solid State Nuclear Magnetic Resonance. 17(1-4). 22–38. 5 indexed citations
17.
Albrecht, Steffen, Thomas Zimmermann, Robert Grützmann, et al.. (1999). Zum redoxsensitiven Verhalten von Selenit in Gegenwart reaktiver Sauerstoffspezies. Medizinische Klinik. 94(S3). 70–73. 4 indexed citations
18.
Scheller, D. & F. Tegtmeier. (1998). Oxygen consumption and energy state in an in vitro model of rat brain perfused with artificial oxygen carrier. Neurological Research. 20(sup1). S37–S39.
19.
Lima, Vera Maura Fernandes de, D. Scheller, F. Tegtmeier, Wolfgang Hanke, & Wolf‐R. Schlue. (1993). Self-sustained spreading depressions in the chicken retina and short-term neuronal-glial interactions within the gray matter neuropil. Brain Research. 614(1-2). 45–51. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Z. Ginos Breakdown of academic impact, for papers by Stephen M. Moerlein Breakdown of academic impact, for papers by Peter Bjurling Breakdown of academic impact, for papers by G. Zürcher Breakdown of academic impact, for papers by Angela Monopoli Breakdown of academic impact, for papers by M. Da Prada Breakdown of academic impact, for papers by Kay Castagnoli Breakdown of academic impact, for papers by Toshiaki Irie Breakdown of academic impact, for papers by Peter K. H. Wong Breakdown of academic impact, for papers by Per‐Göran Gillberg
Rankless by CCL
2026